Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QX005N injection in adults with chronic rhinosinusitis with nasal polyps (CRSwNP)
CTR20223317Phase 2Completed
- Sponsor
- Qiansin
- Start
- Jan 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of QX005N in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Qiansin. Started Jan 2023; status: completed.
02
Drugs
QX005N
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on CTR20223317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223317.